1. Two Armies: Human and Divine
For decades, our fight against cancer has relied on what I call the “human army.” We’ve used scalpels and surgeons. We’ve used chemicals and chemotherapy. We’ve used radiation and isotopes. And each of these has saved lives. Each of them reflects incredible human progress. But today, I want to offer you a different perspective—one rooted in biology, science, and something deeper. Because within each of us lies another army—a God-given force—the immune system. It is precise. It is tireless. And it is already in us, waiting to be activated.
2. The Identity Crisis: Friend or Foe?
So why has cancer remained so hard to defeat? The problem is simple, but profound: Cancer cells come from us. They begin as “self.” They look familiar to our immune system. And by the time they mutate and become dangerous, our immune defenses still hesitate. They see a former friend, not a current threat. This is the core challenge—our God-given army cannot distinguish the enemy from the ally. The cancer cell used to be a citizen of our body. Now it’s a traitor. But we now have the tools to retrain this divine army.
3. Teaching the Immune System to Recognize the Enemy
Thanks to modern biotechnology, we can now educate the immune system to see clearly. With T-cell therapy, we equip our own white blood cells to hunt and destroy cancer. With checkpoint inhibitors, we remove the brakes that cancer exploits to hide. With biosignal modulation, we whisper to the immune system: “This cell has turned against you. It must be stopped.” We are no longer inventing weapons. We are awakening the warrior within.
4. AI: The Intelligence Behind Precision
But the immune system needs a map. It needs intelligence. It needs a compass. This is where Artificial Intelligence comes in. Imagine sorting through billions of genomic codes, protein sequences, and metabolic reactions. No human can do that alone. But AI can. With the power of data, we can now scan a patient’s entire molecular profile, and say: “This therapy, for this person, for this type of cancer, right now.” It is not just personalized medicine. It is precision healing.
5. Health Economics: Longevity Has Value
Let me shift perspectives. In the United States, we spend $11,900 per person per year to reach a life expectancy of 79 years. In Cuba, we spend far less—and achieve nearly the same. In Indonesia, we spend just $140—and reach 72. The difference is not just in years, but in how we invest in those years. Longevity is not just a blessing—it is an asset. When people live longer, they consume more, contribute more, and sustain more. So when we invest in technologies that enable immune-based, AI-powered therapies, we are not just saving lives—we are building futures.
6. The Spiritual and Economic Case
This work is not only scientific. It is also spiritual. It tells us that what God placed within us—the immune system—is not obsolete, but our greatest untapped ally. We must stop seeing medicine only as something to be imposed from outside. The next frontier is to activate what’s already inside. And for investors, I say this: The returns on these breakthroughs are not just measured in dollars. They are measured in years of life, families reunited, and potential fulfilled.
7. Final Words
This is our moment. To fight not just harder—but smarter. To heal not just with drugs—but with data, purpose, and belief. To transform cancer treatment from reaction to revelation. So to all of you—researchers, policymakers, investors, and believers in progress: Let us build the future of cancer care together— Where we do not fear the disease, because we have faith in our defenses. Where we do not only cut or burn, but awaken and guide. Where God’s army within us becomes the greatest healer of all.